HRH1 and myeloid sarcoma: More recently, gene-microarray analysis has shown that H1R expression is upregulated in MS lesions (Lock et al., 2002), and epidemiological studies suggest a protective effect of brain penetrating H1R antagonists (Alonso et al., 2006).